Cached score snapshot
US.LH · Labcorp
110分制 44.5/110;5D動能v2 7/50;排序分 51.5/160
Score breakdown
避免
Score and price trend
Main score, 5D momentum v2, close price, and improving or exit-review turn signals are plotted from archived daily snapshots.
Move the mouse over the chart lines to inspect readings.
- Main score
- 5D momentum v2
- Candlestick
- Historical projection
- Score turn
- Setup grade
| Model | Median | P25/P75 | 歷史相似情境上漲比例 | Down5 | Actual / compare |
|---|---|---|---|---|---|
| Rolling DOE best | +0.23% | -1.62% / +4.04% | 53.8% | 3.8% | Actual outcome pending · 1 / 3 bars observed |
| 30D observation | +6.90% | -1.01% / +14.12% | 70% | 13.8% | Actual outcome pending · 1 / 30 bars observed |
| Historical projection 10D n=160 | +0.39% | -1.55% / +3.41% | 54.4% | 4.4% | Actual outcome pending · 1 / 10 bars observed |
歷史情境統計基於已存檔相似 setup;圖中投影中位線為統計中位數的線性插值展示,並非價格路徑預測或買賣建議。
2026-06-18 → 2026-10-26 · 90 archived points · 3 Improving turn signal · 6 Deteriorating signal
Summary
score_with_momentum_v2 = main score + 5D momentum v2
Rolling setup rating
Setup quality, historical edge, and risk are combined into a rolling S/A/B/C/D/F grade for this snapshot date.
Score turn monitor
Has the score quality changed?
Run more market refreshes to build enough archived points for a turn check.
Signals
技術信號 16.8 · 市場環境 8 · 5D動能v2 7 · VCP PASS
INSTITUTIONAL_DATA_OPTIONAL: Institutional ownership unavailable; neutral money-flow treatment used. FMP_INSTITUTIONAL_FAILED: FMP HTTP 402
Audit trace
Full calculation detail
Calculation detail · 8 sections
Market inputs
Metrics snapshot
110-point main rating
基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10
基本面 — 3.3/5 · 一般
Sub-items
資金流 — 5.2/20 · 較差
Sub-items
institutional
details
warning
市場環境 — 8/15 · 較差
Sub-items
vix
details
trend
details
qqq
spy
催化劑 — 2/20 · 較差
Sub-items
catalyst
details
風險管理 — 7.2/10 · 良好
Sub-items
position
details
stopLevels
strength_details
diversification
details
技術信號 — 16.8/30 · 較差
Sub-items
vcpPayload
vcp_metrics
情緒分析 — 2/10 · 較差
Sub-items
sentiment
details
sentimentData
Dimension contribution
5D momentum v2 breakdown
Cursor_18.25 5D momentum v2 0-50
Risk management
position
details
stopLevels
strength_details
diversification
details
Calculation audit log
基本面分析總分: 3.3/5分 資金流分析總分: 5.2/20分 市場環境分析總分: 8/15分 催化劑分析: 2/20分 風險管理總分: 7.2/10分 技術信號分析總分: 16.8/30分 情緒分析: 2/10分 共振率(僅顯示不加分): 0%
Technical indicators
adx
atr
cci
cmf
kdj
mfi
obv
rsi
sar
ma50
macd
vwap
volume
derived
ma_cross
bollinger
rsi_short
macd_short
volume_ratio
Raw calculation JSON
{
"risk": {
"level": "Medium",
"reason": "risk management score >= 6.5/10",
"position": {
"score": 1.4,
"details": {
"atrPct": 2.4408042878437097,
"turnoverUsdM": 223.15560754,
"liquidityPoints": 0.4,
"volatilityPoints": 1
}
},
"rrPoints": 1.4,
"stopLevels": {
"symbol": "US.LH",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 299.9178,
"strength_details": {
"ma_score": 1.5,
"atr_score": 2,
"rsi_score": 2.5,
"macd_score": 1.5,
"volume_score": 2
},
"market_adjustment": 1,
"risk_reward_ratio": 1.2,
"stop_loss_percent": 4.9,
"take_profit_price": 333.5882,
"target_multiplier": 1.9,
"technical_strength": 1.88,
"take_profit_percent": 5.8
},
"positionPoints": 1.4,
"stopLossPoints": 2.4,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.2,
"stopLossPercent": 4.8816085756874195,
"diversificationPoints": 2
},
"total": {
"max": 160,
"result": 51.5,
"formula": "score_with_momentum_v2 = main_score + momentum_5d_v2_score",
"baseScore": 44.5,
"modelVersion": "cursor_18_27_news_v2_160",
"momentum5dScore": 7
},
"market": {
"ma20": 327.9795,
"ma50": 310.0886,
"close": 315.31,
"prevClose": 311.54,
"avgVolume20": 689637,
"volumeRatio": 1.03,
"changePercent": 1.21
},
"sources": {
"catalyst": "finnhub_news_keyword_model",
"sentiment": "finnhub_news_keyword_model",
"fundamentals": "fmp_stable",
"institutional": null,
"marketContext": "twelvedata+fred"
},
"barCount": 60,
"momentum": {
"max": 50,
"result": 7,
"details": {
"ret_5d": -0.0354247901304785,
"max_score": 50,
"max_total": 50,
"raw_total": 7,
"vcp_bonus": 2,
"vol_ratio": 1.0468431289890765,
"ret_points": 0,
"vol_points": 2,
"range_ratio": 1.129637608540715,
"volat_points": 0,
"day_range_pct": 0.026244013827661596,
"model_version": "cursor_18_27_news_v2_160",
"available_bars": 30,
"breakout_points": 0,
"partial_history": false,
"pullback_points": 3,
"breakout_vol_bonus": 0,
"first_breakout_20d": false,
"return_window_days": 5,
"first_breakout_bonus": 0,
"breakout_quality_points": 0
},
"formula": "Cursor_18.25 5D momentum v2 0-50",
"modelVersion": "cursor_18_27_news_v2_160"
},
"scoreMax": 110,
"composite": {
"max": 160,
"result": 51.5,
"formula": "Cursor_18.25 ranking score v2 (score_with_momentum_v2)",
"weights": [
{
"raw": 3.3,
"label": "基本面",
"weight": "5/110",
"normalized": 66,
"contribution": 3.3
},
{
"raw": 5.2,
"label": "資金流",
"weight": "20/110",
"normalized": 26,
"contribution": 5.2
},
{
"raw": 8,
"label": "市場環境",
"weight": "15/110",
"normalized": 53.33,
"contribution": 8
},
{
"raw": 2,
"label": "催化劑",
"weight": "20/110",
"normalized": 10,
"contribution": 2
},
{
"raw": 7.2,
"label": "風險管理",
"weight": "10/110",
"normalized": 72,
"contribution": 7.2
},
{
"raw": 16.8,
"label": "技術信號",
"weight": "30/110",
"normalized": 56,
"contribution": 16.8
},
{
"raw": 2,
"label": "情緒分析",
"weight": "10/110",
"normalized": 20,
"contribution": 2
}
],
"modelVersion": "cursor_18_27_news_v2_160"
},
"momentumMax": 50,
"scoreStatus": "checked",
"standard110": {
"rating": "避免",
"result": 44.5,
"details": [
"基本面分析總分: 3.3/5分",
"資金流分析總分: 5.2/20分",
"市場環境分析總分: 8/15分",
"催化劑分析: 2/20分",
"風險管理總分: 7.2/10分",
"技術信號分析總分: 16.8/30分",
"情緒分析: 2/10分",
"共振率(僅顯示不加分): 0%"
],
"formula": "基本面5 + 資金流20 + 市場環境15 + 催化劑20 + 風險管理10 + 技術信號30 + 情緒10",
"dimensionScores": {
"催化劑": 2,
"基本面": 3.3,
"資金流": 5.2,
"市場環境": 8,
"情緒分析": 2,
"技術信號": 16.8,
"風險管理": 7.2
},
"dimensionDetails": {
"催化劑": {
"max": 20,
"grade": "較差",
"items": {
"catalyst": {
"score": 2,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 4,
"catalystCount": 0
}
},
"catalystPoints": 2
}
},
"基本面": {
"max": 5,
"grade": "一般",
"items": {
"pbPoints": 0.4,
"pePoints": 0.2,
"epsPoints": 0.6,
"roePoints": 0.4,
"debtPoints": 0.4,
"marginPoints": 0,
"turnoverUsdM": 223.15560754,
"volumePoints": 0.5,
"revenuePoints": 0,
"dividendPoints": 0.3,
"marketCapPoints": 0.5
},
"source": "fmp_stable"
},
"資金流": {
"max": 20,
"grade": "較差",
"items": {
"cmfPoints": 0.8,
"mfiPoints": 0.8,
"obvPoints": 0.8,
"vwapPoints": 0.8,
"institutional": {
"score": 2,
"details": {
"source": "optional-neutral",
"warning": {
"code": "INSTITUTIONAL_DATA_OPTIONAL",
"symbol": "US.LH",
"message": "Institutional ownership is unavailable; neutral 2/4 money-flow treatment used."
},
"optional": true,
"holderCount": null,
"holderPoints": 2,
"top10ShareRatio": null,
"concentrationPenalty": 0
}
},
"institutionPoints": 2
}
},
"市場環境": {
"max": 15,
"grade": "較差",
"items": {
"vix": {
"score": 2.4,
"details": {
"source": "twelvedata+fred",
"vixClose": 15.84
}
},
"trend": {
"score": 1.7999999999999998,
"details": {
"qqq": {
"ma20": 714.57349835,
"ma50": 710.3379992999998,
"name": "QQQ",
"close": 709.17999,
"points": 0.4
},
"spy": {
"ma20": 766.10599295,
"ma50": 758.9384004200002,
"name": "SPY",
"close": 760.88,
"points": 1.4
},
"source": "twelvedata+fred"
}
},
"atrPct": 2.4408042878437097,
"atrPoints": 3,
"cciPoints": 0.8,
"vixPoints": 2.4,
"marketTrendPoints": 1.7999999999999998
}
},
"情緒分析": {
"max": 10,
"grade": "較差",
"items": {
"sentiment": {
"score": 2,
"details": {
"source": "finnhub_news_keyword_model",
"articleCount": 4,
"negativeHits": 0,
"positiveHits": 0,
"sentimentScoreRaw": 0
}
},
"sentimentData": {
"raw": [
{
"id": 142117742,
"url": "https://finnhub.io/api/news?id=ffc7e0ffc8533572d29c7f7f1460c55ffc07260cc793e2874e0892484ed32fb8",
"image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"source": "SeekingAlpha",
"related": "LH",
"summary": "2026-09-12. The following slide deck was published by Labcorp Holdings Inc.",
"category": "company",
"datetime": 1789240426,
"headline": "Labcorp Holdings Inc. (LH) Analyst/Investor Day - Slideshow"
},
{
"id": 142077021,
"url": "https://finnhub.io/api/news?id=5df4261d44813aee91d19bafe32c07f4018e7531d974dcaea2ec60421edcb85a",
"image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"source": "SeekingAlpha",
"related": "LH",
"summary": "Labcorp Holdings Inc. (LH) Analyst/Investor Day September 10, 2026 9:00 AM EDTCompany ParticipantsDewey Steadman - Senior Vice President of Investor...",
"category": "company",
"datetime": 1789100225,
"headline": "Labcorp Holdings Inc. (LH) Analyst/Investor Day Transcript"
},
{
"id": 141364799,
"url": "https://finnhub.io/api/news?id=31373309b32b11664a69313cdfde6a304286bcf2a7d2f7f46816cf13cc737438",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp Holdings (NYSE: LH) introduced the Elecsys pTau-217 blood test, the first FDA-cleared single biomarker test for Alzheimer’s disease, expanding access through primary and specialty care. The Elecsys pTau-217 test is positioned to support clinical assessment of cognitive decline with a minimally invasive blood draw instead of more invasive procedures. Labcorp announced a long-term alliance with the National Association of Community Health Centers to support clinical leadership and...",
"category": "company",
"datetime": 1787887077,
"headline": "Labcorp Holdings (LH) Unveiled The First FDA Cleared Single Biomarker Alzheimer’s Blood Test"
},
{
"id": 141328528,
"url": "https://finnhub.io/api/news?id=41d4184e9828e30deff21e42d2056e1128eedab4a275a35a6c0cb91c26459fec",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Over the past six months, Labcorp has been a great trade, beating the S&P 500 by 9.5%. Its stock price has climbed to $339.34, representing a healthy 20% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.",
"category": "company",
"datetime": 1787671604,
"headline": "3 Reasons LH is Risky and 1 Stock to Buy Instead"
}
],
"raw_source": [
{
"id": 142141684,
"url": "https://finnhub.io/api/news?id=bac7fa50ee6b41b162de991a95b34a7c95a15bc21c5b3a1bb05bd9099e917aea",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp Holdings on Thursday presented a comprehensive growth strategy and long-term financial forecast during its 2026 Investor Day. The health care company emphasized its innovation roadmap, technological advancements and solid financial expectations for the coming years. Reaffirming Financial Targets The...",
"category": "company",
"datetime": 1789414224,
"headline": "Labcorp Bets Big on AI, Specialty Testing to Drive Growth Through 2029"
},
{
"id": 142139696,
"url": "https://finnhub.io/api/news?id=9c091855b48168bb8f970b17a9fca4589e52c76e20a31769fc4267b17c4f227c",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.",
"category": "company",
"datetime": 1789401810,
"headline": "1 Mid-Cap Stock with Competitive Advantages and 2 That Underwhelm"
},
{
"id": 142117742,
"url": "https://finnhub.io/api/news?id=ffc7e0ffc8533572d29c7f7f1460c55ffc07260cc793e2874e0892484ed32fb8",
"image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"source": "SeekingAlpha",
"related": "LH",
"summary": "2026-09-12. The following slide deck was published by Labcorp Holdings Inc.",
"category": "company",
"datetime": 1789240426,
"headline": "Labcorp Holdings Inc. (LH) Analyst/Investor Day - Slideshow"
},
{
"id": 142088016,
"url": "https://finnhub.io/api/news?id=9f1de9a72a876b2cb6e7aaa3e81ad72df2eeae2507ca22fd43cbc726b2a177eb",
"image": "https://cdn.benzinga.com/files/images/story/2026/09/11/benzinga-deal-dispatch2.jpg?width=2048&height=1536",
"source": "Benzinga",
"related": "LH",
"summary": "Read this week's top deal updates, including Bending Spoons' Miro deal, Chime's Stride Bank purchase, and the LIV Golf bankruptcy.",
"category": "company",
"datetime": 1789132210,
"headline": "Deal Dispatch: Bending Spoons Acquires Miro For $1.35B, Kinetik Up For Sale, LIV Golf Bankruptcy"
},
{
"id": 142091766,
"url": "https://finnhub.io/api/news?id=c2b6e7602901cb4d1f9b46629e5ecedffb60499551a18f33e89b1ad14fd6a13f",
"image": "",
"source": "Benzinga",
"related": "LH",
"summary": "UBS analyst Kevin Caliendo maintains Labcorp Holdings (NYSE:LH) with a Buy and raises the price target from $361 to $380.",
"category": "company",
"datetime": 1789121483,
"headline": "UBS Maintains Buy on Labcorp Holdings, Raises Price Target to $380"
},
{
"id": 142091767,
"url": "https://finnhub.io/api/news?id=434ff13de1105f78ab6457991f1081e8e419a33bbbea4206c4ddc7ea21c8f598",
"image": "",
"source": "Benzinga",
"related": "LH",
"summary": "Barclays analyst Luke Sergott maintains Labcorp Holdings (NYSE:LH) with a Equal-Weight and raises the price target from $320 to $330.",
"category": "company",
"datetime": 1789119938,
"headline": "Barclays Maintains Equal-Weight on Labcorp Holdings, Raises Price Target to $330"
},
{
"id": 142077021,
"url": "https://finnhub.io/api/news?id=5df4261d44813aee91d19bafe32c07f4018e7531d974dcaea2ec60421edcb85a",
"image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
"source": "SeekingAlpha",
"related": "LH",
"summary": "Labcorp Holdings Inc. (LH) Analyst/Investor Day September 10, 2026 9:00 AM EDTCompany ParticipantsDewey Steadman - Senior Vice President of Investor...",
"category": "company",
"datetime": 1789100225,
"headline": "Labcorp Holdings Inc. (LH) Analyst/Investor Day Transcript"
},
{
"id": 142063466,
"url": "https://finnhub.io/api/news?id=a8350c91ca0c9c7be6ba16c0c43c08cb4212e5eb4885ebed5c796749a1089fb7",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.",
"category": "company",
"datetime": 1789058464,
"headline": "1 Profitable Stock Worth Your Attention and 2 Facing Headwinds"
},
{
"id": 142060189,
"url": "https://finnhub.io/api/news?id=b95dab67a1a5dcc508f3a0d1c31f07d8c75d434e82fea7a6fbf265ba9a67644d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today will host its 2026 Investor Day at 9 a.m. ET, where the company will provide an in-depth review of its growth strategy, innovation roadmap and long-term financial outlook. The event will highlight Labcorp's unique position at the intersection of diagnostics, biopharma, science and technology and how the company is creating long-term value for customers and shareholders.",
"category": "company",
"datetime": 1789038000,
"headline": "Labcorp Highlights Strategic Priorities Driving Durable Growth and Shareholder Value at 2026 Investor Day"
},
{
"id": 142065725,
"url": "https://finnhub.io/api/news?id=be8fbd5a07906300d574bb92911cb7e143e9123fd1d130bda22f45eb4233f9fc",
"image": "",
"source": "Benzinga",
"related": "LH",
"summary": "Reaffirms full-year 2026 guidanceProvides long-term outlook through 2029, with compound annual revenue growth of 5% to 8% and compound annual adjusted earnings per share (EPS) growth of 8.5% to 11.5%Outlines strategic",
"category": "company",
"datetime": 1789024607,
"headline": "Labcorp Provides Long-Term Outlook Through 2029, With 5%-8% Revenue CAGR And 8.5%-11.5% Adj EPS CAGR"
},
{
"id": 142065726,
"url": "https://finnhub.io/api/news?id=a7899a733af36b0a3d14a6f9d2f8cb9f0271ed5e80f2cd8640428534cb6868da",
"image": "",
"source": "Benzinga",
"related": "LH",
"summary": "Labcorp Holdings (NYSE:LH) affirms FY2026 Adj EPS guidance from $18.10-$18.55 to $18.10-$18.55 vs $18.01 analyst estimate. Affirms FY2026 sales outlook from $14.710 billion-$14.827 billion to $14.710 billion-$14.827",
"category": "company",
"datetime": 1789024298,
"headline": "Labcorp Holdings Affirms FY2026 Adj EPS Guidance of $18.10-$18.55 vs $18.01 Est; Affirms FY2026 Sales Guidance of $14.710B-$14.827B vs $14.707B Est"
},
{
"id": 142024759,
"url": "https://finnhub.io/api/news?id=e111ae148fe380853bcfd087e297300ac854180e6137e84a87ca08c1774f83c3",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.",
"category": "company",
"datetime": 1788958500,
"headline": "Moonwalk Biosciences Announces $70 Million Series B: NYSE Content Update"
},
{
"id": 141951219,
"url": "https://finnhub.io/api/news?id=26cd988cd102699bc607d760f6bd9b391d131e19d5c76e1150c84f7afc4ce878",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the acquisition of MLM Medical Labs (MLM), a leading global central and specialty laboratory provider with operations across the United States, Germany and South Africa. Financial terms of the transaction were not disclosed.",
"category": "company",
"datetime": 1788872700,
"headline": "Labcorp Acquires MLM Medical Labs, Expanding Global Central Laboratory and Biomarker Capabilities for Clinical Trials"
},
{
"id": 141951936,
"url": "https://finnhub.io/api/news?id=b21a621d16f71d83b49537b7302fb8eba6895c3fb7b46bafa5f8a26440785630",
"image": "",
"source": "Benzinga",
"related": "LH",
"summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the acquisition of MLM Medical Labs (MLM), a leading global central and specialty laboratory provider with",
"category": "company",
"datetime": 1788858623,
"headline": "Labcorp Acquires MLM Medical Labs; Financial Terms Not Disclosed"
},
{
"id": 141362285,
"url": "https://finnhub.io/api/news?id=7cc64918f3b60782ab2fbcbefa34e6aa0b5f06d064dc3153c595d7e299f4f42e",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Its deepest fall inside a market shock is not its deepest fall, and that gap is what a holder should size for.",
"category": "company",
"datetime": 1788208182,
"headline": "Market Shocks Are Not Where Hims & Hers Health Stock Has Fallen Furthest"
},
{
"id": 141364803,
"url": "https://finnhub.io/api/news?id=81fd2d01385ccdaa2f54d388659f34035e4017a6ddcf58f461004c4142cd376d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory solutions, today announced enhancements to the digital experience of Labcorp Global Trial Connect™, the company's portfolio of clinical trial services, data and technology that enhances and accelerates delivery. The newly redesigned platform introduces new capabilities across the Labcorp Sponsor™ and Labcorp Investigator™ portal experiences of Global Trial Connect, providing greater visibility across studies, simplify",
"category": "company",
"datetime": 1788177600,
"headline": "Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity"
},
{
"id": 141364798,
"url": "https://finnhub.io/api/news?id=22001312f7ec803e2ef7a0cae3411b2f7deaa54910259b1aa3250d27030abf9f",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Tuesday, Sept. 15, at 11:30 a.m. ET.",
"category": "company",
"datetime": 1787923800,
"headline": "Labcorp to Speak at the Morgan Stanley 24th Annual Global Healthcare Conference"
},
{
"id": 141364799,
"url": "https://finnhub.io/api/news?id=31373309b32b11664a69313cdfde6a304286bcf2a7d2f7f46816cf13cc737438",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp Holdings (NYSE: LH) introduced the Elecsys pTau-217 blood test, the first FDA-cleared single biomarker test for Alzheimer’s disease, expanding access through primary and specialty care. The Elecsys pTau-217 test is positioned to support clinical assessment of cognitive decline with a minimally invasive blood draw instead of more invasive procedures. Labcorp announced a long-term alliance with the National Association of Community Health Centers to support clinical leadership and...",
"category": "company",
"datetime": 1787887077,
"headline": "Labcorp Holdings (LH) Unveiled The First FDA Cleared Single Biomarker Alzheimer’s Blood Test"
},
{
"id": 141328527,
"url": "https://finnhub.io/api/news?id=2c6fa2557dbaec4227f8dbd5021b3fcd3bd488b0437bacab7dbbf50e03b31ffb",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Do Wall Street analysts favor Labcorp’s stock, given its solid performance?",
"category": "company",
"datetime": 1787755302,
"headline": "Are Wall Street Analysts Bullish on Labcorp Holdings Stock?"
},
{
"id": 141328528,
"url": "https://finnhub.io/api/news?id=41d4184e9828e30deff21e42d2056e1128eedab4a275a35a6c0cb91c26459fec",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Over the past six months, Labcorp has been a great trade, beating the S&P 500 by 9.5%. Its stock price has climbed to $339.34, representing a healthy 20% increase. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.",
"category": "company",
"datetime": 1787671604,
"headline": "3 Reasons LH is Risky and 1 Stock to Buy Instead"
},
{
"id": 141328529,
"url": "https://finnhub.io/api/news?id=1bc29ddfb3cac19c10a5e8e6813ba6adf0b2ec574897211762477575abdd5086",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "DHR's Biotechnology segment grows as China demand, bioprocessing and improving discovery markets offset regional headwinds.",
"category": "company",
"datetime": 1787666640,
"headline": "Danaher Rides on Strength in Biotechnology Segment: Will It Sustain?"
},
{
"id": 141328530,
"url": "https://finnhub.io/api/news?id=987bec09fcd486813ecb7d3a7687216add4739a533d76a32cbe7bc626b57e328",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "LH's specialty-testing expansion, strategic partnerships and buybacks support growth, while reimbursement and cost pressures pose risks.",
"category": "company",
"datetime": 1787664000,
"headline": "Should You Continue to Hold Labcorp Stock in Your Portfolio?"
},
{
"id": 141313625,
"url": "https://finnhub.io/api/news?id=bf0775da347333c805e2171fe144b86c4c7a909f48cddbae25b312b5df9f684d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys® pTau-217 test following clearance by the U.S. Food and Drug Administration (FDA). Developed by Roche Diagnostics, the blood test aids in identifying amyloid pathology associated with Alzheimer's disease in individuals 55 and older with signs, symptoms or complaints of cognitive decline. Elecsys® pTau-217 is the first and only FDA-cleared single-biomarker blood test",
"category": "company",
"datetime": 1787569320,
"headline": "Labcorp to Offer First FDA-Cleared Blood Test to Detect Alzheimer's Disease Pathology in Both Primary and Specialty Care Settings"
},
{
"id": 141311514,
"url": "https://finnhub.io/api/news?id=ea8b7c842e72dc4a35a5969cc5038e4bcce5289bd7456967e5649d34ae7c971c",
"image": "",
"source": "Benzinga",
"related": "LH",
"summary": "Elecsys® pTau-217 is the first and only FDA-cleared single-biomarker blood test to both rule in and rule out amyloid pathology across specialty and primary care settingsMeasures phosphorylated Tau 217 (pTau-217), an",
"category": "company",
"datetime": 1787555281,
"headline": "Labcorp To Offer Elecsys pTau-217 Test Following Clearance By FDA"
},
{
"id": 141275203,
"url": "https://finnhub.io/api/news?id=089773ba910b7d77165aa048f75b768edf24f1414da740123cd9e15d62e665de",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "The gap between its revenue multiple and its cash multiple is margin, and the company is spending it on purpose.",
"category": "company",
"datetime": 1787257290,
"headline": "Hims & Hers Health Stock Trades Below The Market On Revenue And Above It On Cash"
},
{
"id": 141266861,
"url": "https://finnhub.io/api/news?id=9cedcdf4c43cd7438e7b70ae9a03e3c4bf570d0f0bd5b655596aaaef72271d12",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "IDEXX raises its 2026 EPS outlook as recurring diagnostics growth, wider margins and international expansion offset softer U.S. veterinary traffic.",
"category": "company",
"datetime": 1787243820,
"headline": "IDXX Raises 2026 EPS Outlook as Diagnostic Growth and Margins Improve"
},
{
"id": 141283687,
"url": "https://finnhub.io/api/news?id=c1083eb5d78d2494cc5298cb1e9b87db833a0270edea2b3e80d13132b8c82147",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "OPKO Health's 12.4% monthly gain is backed by narrower losses and better margins, though profitability and clinical execution remain key risks.",
"category": "company",
"datetime": 1787160900,
"headline": "OPK Climbs 12.4% in the Past Month: Can the Stock Rally Keep Going?"
},
{
"id": 141283677,
"url": "https://finnhub.io/api/news?id=e5c485442820baef6b2efbdde6716d59d47ff872afaf6e93bbdacc8bd228238b",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and the National Association of Community Health Centers (NACHC) today announced a strategic alliance to strengthen leadership development, support practice improvement and advance community health initiatives across the nation's Community Health Center (CHC) network. As part of the collaboration, the organizations are launching the NACHC Leadership Exchange for Chief Medical Officers, designed to support cu",
"category": "company",
"datetime": 1787054400,
"headline": "Labcorp and NACHC Launch Strategic Alliance to Strengthen Health Center Leadership and Advance Community Health"
},
{
"id": 141249550,
"url": "https://finnhub.io/api/news?id=e4a4007233f345246016d931e5f8bdf59aed8a125f2b5b12aef7d10c07478b65",
"image": "",
"source": "Benzinga",
"related": "LH",
"summary": "Collaboration will support leadership development, practice improvement and innovation across the nation's Community Health CentersBURLINGTON, N.C. and BETHESDA, Md., Aug. 18, 2026 /PRNewswire/ -- Labcorp (NYSE:LH),",
"category": "company",
"datetime": 1787036885,
"headline": "Labcorp And NACHC Announce Strategic Alliance To Support Practice Improvement And Advance Community Health Initiatives Across Community Health Center Network"
},
{
"id": 141283671,
"url": "https://finnhub.io/api/news?id=bc11bca6e6fed5f8b9cc8192451e1dd125d0d9e8ada4eb2d22092d7b3fd87f6d",
"image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
"source": "Yahoo",
"related": "LH",
"summary": "Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced it will host an Investor Day on Thursday, September 10, 2026, from 9 a.m. to noon ET.",
"category": "company",
"datetime": 1786971600,
"headline": "Labcorp to Host Investor Day on September 10, 2026"
},
{
"id": 141231125,
"url": "https://finnhub.io/api/news?id=20166a2b2acd2263cfdbcc99fc419c59e514054bea615fc73fdbae8d84095aeb",
"image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1445262091/image_1445262091.jpg?io=getty-c-w1536",
"source": "SeekingAlpha",
"related": "LH",
"summary": "Healthcare sector valuation check: equipment undervalued, providers near baseline, pharma/biotech overvalued. Learn more about IHF ETF here.",
"category": "company",
"datetime": 1786867596,
"headline": "IHF: Healthcare Dashboard For August"
}
],
"data_source": "finnhub_news_keyword_model",
"article_count": 4,
"negative_hits": 0,
"positive_hits": 0,
"recomputed_at_score": true,
"sentiment_score_raw": 0,
"source_article_count": 31,
"discarded_article_count": 27
},
"sentimentPoints": 2
}
},
"技術信號": {
"max": 30,
"raw": 16.8,
"grade": "較差",
"items": {
"bbPoints": 2.4,
"adxPoints": 3,
"sarPoints": 1.2000000000000002,
"vcpPoints": 2.7,
"macdPoints": 2.4,
"vcpPayload": {
"vcp_pass": true,
"vcp_score": 2.7,
"vcp_reason": "波幅收縮(13.1%→10.2%);跌縮量(近10日4日);站上MA50;升放量(近10日2日);Ready=Y;Confirm=Y",
"vcp_metrics": {
"up_days": 2,
"vol_ref": 640980,
"down_days": 7,
"vcp_ready": true,
"above_ma50": true,
"avg_vol_10": 712850,
"avg_vol_20": 676065,
"avg_vol_30": 640980,
"range_pct_10": 0.10224854904696958,
"range_pct_20": 0.11528330849005727,
"range_pct_30": 0.13072848942310733,
"up_expand_ok": true,
"lookback_used": 59,
"near_20d_high": false,
"contraction_ok": true,
"down_shrink_ok": true,
"up_expand_days": 2,
"breakout_20d_ok": false,
"vol_ratio_10_30": 1.1121251833130519,
"dist_to_20d_high": 0.0775014358543427,
"down_shrink_days": 4,
"breakout_level_20d": 341.79999,
"vcp_breakout_confirm": true,
"contraction_ratio_10_30": 0.7821443474041727
},
"vcp_name_en": "Volatility Contraction Pattern",
"vcp_name_zh": "波動收縮形態",
"vol_contraction": true
},
"kdjAdxPoints": 0.5,
"rsiKdjPoints": 0.8,
"volumeWeight": 2,
"maCrossPoints": 1.6,
"shortRsiPoints": 0,
"shortMacdPoints": 0.4,
"volConfirmPoints": 0.6,
"volumePointsTechnical": 1.2
}
},
"風險管理": {
"max": 10,
"grade": "良好",
"items": {
"position": {
"score": 1.4,
"details": {
"atrPct": 2.4408042878437097,
"turnoverUsdM": 223.15560754,
"liquidityPoints": 0.4,
"volatilityPoints": 1
}
},
"rrPoints": 1.4,
"stopLevels": {
"symbol": "US.LH",
"rr_range": "1:1.0-1:2.5",
"risk_profile": "中等",
"stop_loss_price": 299.9178,
"strength_details": {
"ma_score": 1.5,
"atr_score": 2,
"rsi_score": 2.5,
"macd_score": 1.5,
"volume_score": 2
},
"market_adjustment": 1,
"risk_reward_ratio": 1.2,
"stop_loss_percent": 4.9,
"take_profit_price": 333.5882,
"target_multiplier": 1.9,
"technical_strength": 1.88,
"take_profit_percent": 5.8
},
"positionPoints": 1.4,
"stopLossPoints": 2.4,
"diversification": {
"score": 2,
"details": {
"method": "sector concentration proxy; no portfolio holdings used",
"sector": "Health Care",
"concentratedSectorPenalty": 0
}
},
"riskRewardRatio": 1.2,
"stopLossPercent": 4.8816085756874195,
"diversificationPoints": 2
}
}
}
},
"modelVersion": "cursor_18_27_news_v2_160",
"providerErrors": [],
"rankingScoreMax": 160,
"dataCompleteness": {
"complete": true,
"missingFields": [],
"optionalInputs": [
"institutionalData"
],
"requiredInputs": [
"fundamentals",
"marketContext.VIX",
"marketContext.SPY",
"marketContext.QQQ",
"catalystData",
"sentimentData",
"ATR",
"sector"
],
"optionalInputWarnings": []
},
"technicalIndicators": {
"adx": 64.29,
"atr": {
"atr": 7.6961,
"rule": "ATR / current price; lower volatility scores higher",
"score": 6,
"atr_pct": 2.44
},
"cci": {
"rule": "Cursor_18.24 CCI bands",
"level": "超買或超賣風險",
"score": 2,
"value": -140.3
},
"cmf": {
"rule": "Cursor_18.24 CMF bands",
"level": "派發",
"score": 2,
"value": -0.0083
},
"kdj": {
"d": 23.56,
"j": 19.19,
"k": 22.11,
"rule": "Cursor_18.24 K/D cross",
"score": 0,
"signal": "死叉"
},
"mfi": {
"rule": "Cursor_18.24 MFI bands",
"level": "超賣或超買風險",
"score": 2,
"value": 25.88
},
"obv": {
"rule": "Cursor_18.24 recent_slope vs previous_slope",
"score": 2,
"trend": "資金流出",
"value": 4811134,
"recentSlope": -220556.6,
"previousSlope": -11260
},
"rsi": 26.19,
"sar": {
"rule": "Cursor_18.24 Parabolic SAR",
"score": 4,
"trend": "下降",
"value": 326.3573,
"position": "SAR喺價上",
"distancePct": 3.5,
"previousTrend": "下降"
},
"ma50": 310.0886,
"macd": {
"macd": 0.9355000997115326,
"trend": "中性偏多",
"signal": 4.900663008923892,
"histogram": -3.965162909212359
},
"vwap": {
"rule": "Cursor_18.24 VWAP 20D consecutive close",
"score": 2,
"value": 326.7878,
"position": "<VWAP",
"consecutiveAbove": 0
},
"volume": {
"rule": "Cursor_18.24 volume ratio",
"level": "有量",
"ratio": 1.03,
"score": 6,
"avgVolume": 689637,
"currentVolume": 707734
},
"derived": {
"ma20": 327.9795,
"ma50": 310.0886,
"prevClose": 311.54,
"avgVolume10": 737973,
"avgVolume20": 689637,
"changePercent": 1.21,
"avgVolumeForScore": 689637
},
"ma_cross": {
"ma20": 327.9795,
"ma50": 310.0886,
"rule": "Cursor_18.24 MA20/MA50 cross",
"cross": "多頭",
"score": 4,
"prevMa20": 328.1205,
"prevMa50": 309.522,
"spreadPct": 5.77,
"isVolumeBreakout": false
},
"bollinger": {
"lower": 310.4269,
"upper": 345.5321,
"position": "中間"
},
"rsi_short": 25.39,
"macd_short": {
"macd": 0,
"trend": "中性",
"signal": 0,
"histogram": 0
},
"volume_ratio": {
"ratio": 1.03
}
}
}
Raw metrics JSON
{
"close": 315.31,
"volume": 707734,
"changePercent": 1.21
}
Scores are derived from cached daily market data using the Cursor_18.25 standard. Solorank.ai provides research support only and does not provide financial advice or buy/sell recommendations.